Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Journal of Patient Experience
|
June 28, 2021
Empathy
Danielle Benedict Sacdalan
Cancer Treatment and Research Communications
|
January 30, 2021
Revisiting a lower starting dose of alectinib in ALK-Positive non-small cell lung cancer
Danielle Benedict Sacdalan, Josephine Anne Lucero
European Journal of Internal Medicine
|
June 16, 2019
White islands in a sea of red: A tropical rash
Josephine Anne Lucero, Danielle Benedict Sacdalan
Oncotargets and Therapy
|
March 29, 2021
The Association Between Inflammation and Immunosuppression: Implications for ICI Biomarker Development
Danielle Benedict Sacdalan, Josephine Anne Lucero
Cancer Treatment and Research Communications
|
March 18, 2020
Giant cell tumor of soft tissue of the nasopharynx: A case report
Emmelyn Buenacosa Nepucpan, Danielle Benedict Sacdalan
Cancer Treatment and Research Communications
|
November 29, 2022
A reduced dosing strategy can work for Alectinib in ALK rearranged non small cell lung cancer
Danielle Benedict Sacdalan, Josephine Anne Lucero
Current Oncology (Toronto, Ont.)
|
January 22, 2024
Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications
Danielle Benedict Sacdalan, Sami Ul Haq, Benjamin H Lok
Oncotargets and Therapy
|
March 6, 2018
Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
Danielle Benedict Sacdalan, Josephine Anne Lucero, Dennis Lee Sacdalan
Ecancermedicalscience
|
June 23, 2020
Treatment of cancer patients during the COVID-19 pandemic in the Philippines
Frederic Ivan Ting, Danielle Benedict Sacdalan, Honey Sarita Abarquez, et al.
Ecancermedicalscience
|
November 19, 2020
Updated general recommendations in cancer management during the COVID-19 pandemic in the Philippines
Frederic Ivan Ting, Marvin Jonne Mendoza, Danielle Benedict Sacdalan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Journal of Patient Experience
|
June 28, 2021
Empathy
Danielle Benedict Sacdalan
Cancer Treatment and Research Communications
|
January 30, 2021
Revisiting a lower starting dose of alectinib in ALK-Positive non-small cell lung cancer
Danielle Benedict Sacdalan, Josephine Anne Lucero
European Journal of Internal Medicine
|
June 16, 2019
White islands in a sea of red: A tropical rash
Josephine Anne Lucero, Danielle Benedict Sacdalan
Oncotargets and Therapy
|
March 29, 2021
The Association Between Inflammation and Immunosuppression: Implications for ICI Biomarker Development
Danielle Benedict Sacdalan, Josephine Anne Lucero
Cancer Treatment and Research Communications
|
March 18, 2020
Giant cell tumor of soft tissue of the nasopharynx: A case report
Emmelyn Buenacosa Nepucpan, Danielle Benedict Sacdalan
Cancer Treatment and Research Communications
|
November 29, 2022
A reduced dosing strategy can work for Alectinib in ALK rearranged non small cell lung cancer
Danielle Benedict Sacdalan, Josephine Anne Lucero
Current Oncology (Toronto, Ont.)
|
January 22, 2024
Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications
Danielle Benedict Sacdalan, Sami Ul Haq, Benjamin H Lok
Oncotargets and Therapy
|
March 6, 2018
Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
Danielle Benedict Sacdalan, Josephine Anne Lucero, Dennis Lee Sacdalan
Ecancermedicalscience
|
June 23, 2020
Treatment of cancer patients during the COVID-19 pandemic in the Philippines
Frederic Ivan Ting, Danielle Benedict Sacdalan, Honey Sarita Abarquez, et al.
Ecancermedicalscience
|
November 19, 2020
Updated general recommendations in cancer management during the COVID-19 pandemic in the Philippines
Frederic Ivan Ting, Marvin Jonne Mendoza, Danielle Benedict Sacdalan, et al.
Page
of 2